KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Gains from Sales and Divestitures (2023 - 2025)

Globus Medical (GMED) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $117000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Sales and Divestitures fell 66.86% year-over-year to $117000.0, compared with a TTM value of $117000.0 through Sep 2025, down 66.86%, and an annual FY2024 reading of $18000.0, down 96.23% over the prior year.
  • Gains from Sales and Divestitures was $117000.0 for Q3 2025 at Globus Medical, up from $20000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $477000.0 in Q4 2023 and bottomed at $5000.0 in Q1 2024.
  • Average Gains from Sales and Divestitures over 3 years is $202666.7, with a median of $117000.0 recorded in 2025.
  • The sharpest move saw Gains from Sales and Divestitures crashed 96.23% in 2024, then skyrocketed 1860.0% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $477000.0 in 2023, then plummeted by 96.23% to $18000.0 in 2024, then skyrocketed by 550.0% to $117000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for GMED at $117000.0 in Q3 2025, $20000.0 in Q2 2025, and $98000.0 in Q1 2025.